- Report
- November 2021
- 1184 Pages
Global
From €5726EUR$6,000USD£4,798GBP
- Report
- November 2021
- 233 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- December 2024
- 322 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- October 2023
- 428 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- October 2022
- 310 Pages
Global
From €3665EUR$3,840USD£3,071GBP
- Report
- August 2021
- 295 Pages
Global
From €3543EUR$3,712USD£2,968GBP
- Book
- September 2023
- 272 Pages
- Book
- March 2022
- 208 Pages
- Book
- December 2023
- 864 Pages
- Book
- March 2018
- 1134 Pages
- Book
- August 2015
- 648 Pages
- Book
- July 2015
- 416 Pages
- Book
- April 2013
- 256 Pages
- Book
- March 2020
- 160 Pages

The Cytogenetics market is a subset of the biotechnology industry that focuses on the study of chromosomes and their role in genetic inheritance. It involves the use of various techniques, such as karyotyping, fluorescent in situ hybridization (FISH), and comparative genomic hybridization (CGH), to analyze and identify chromosomal abnormalities. Cytogenetics is used to diagnose and treat a variety of genetic disorders, including Down syndrome, Turner syndrome, and Klinefelter syndrome.
Cytogenetics is a rapidly growing field, with advances in technology allowing for more accurate and efficient diagnosis of genetic disorders. This has led to increased demand for cytogenetic services, as well as the development of new products and services.
Companies in the Cytogenetics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Bio-Rad Laboratories. Show Less Read more